Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients
|ClinicalTrials.gov Identifier: NCT00507052|
Recruitment Status : Unknown
Verified July 2007 by Assaf-Harofeh Medical Center.
Recruitment status was: Not yet recruiting
First Posted : July 25, 2007
Last Update Posted : July 25, 2007
In our opinion, it is worth to check an ability of antioxidant therapy to produce a favorable effect on Residual Renal Function.
The aim of our study is to investigate the effect of N-acetylsysteine on RRF in prevalent HD patients.
|Condition or disease||Intervention/treatment||Phase|
|Hemodialysis Renal Failure||Drug: N-acetylcysteine||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00507052
|Contact: Leonid S Feldman, MD||+972-8-9779383 ext +email@example.com|
|Assaf Harofeh||Not yet recruiting|
|Zerifin, Israel, 70300|
|Contact: Leonid S Feldman, MD +972-8-9779383 ext +972 firstname.lastname@example.org|
|Principal Investigator:||Leonid S Feldman, MD||Assaf Harofeh MC|